The quasi-morphine withdrawal syndrome: Effect of cannabinol, cannabidiol and tetrahydrocannabinol
- 1 July 1985
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 23 (1) , 13-15
- https://doi.org/10.1016/0091-3057(85)90122-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Interactions among the cannabinoids in the antagonism of the abdominal constriction response in the mousePsychopharmacology, 1979
- The attenuation by ? 9-Tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in ratsPsychopharmacology, 1979
- Inhibition of naloxone-induced withdrawal in morphine dependent mice by l-trans-Δ9-tetrahydrocannabinolEuropean Journal of Pharmacology, 1976
- Tetrahydrocannabinol-attenuated abstinence and induced rotation in morphine-dependent rats: Possible involvement of dopamineNeuropharmacology, 1975
- The effect of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol on ether anaesthesia in miceJournal of Pharmacy and Pharmacology, 1975
- Morphine-Dependent Rats: Blockade of Precipitated Abstinence by TetrahydrocannabinolScience, 1975
- Quasi morphine-abstinence syndromeNature, 1974
- Interaction of Δ9-tetrahydrocannabinol and cannabidiol on intestinal motility in miceJournal of Pharmacy and Pharmacology, 1974
- The effect of cannabinoids on intestinal motility and their antinociceptive effect in miceBritish Journal of Pharmacology, 1973
- Analgesic activity of ?9-tetrahydrocannabinol in the rat and mousePsychopharmacology, 1972